​Leadership

Adedigbo Fasanmade, BPharm., PhD., FIF.
President

Adedigbo A. Fasanmade is an accomplished educator, life scientist, and innovator. At this turn in his career, he serves as the CEO of Fastribion. He provides the vision and direction of accelerated drug development processes. Prior to his present role, Adedigbo Fasanmade ​served as the Global Director of Quantitative Clinical Pharmacology and Translational Research, in oncology and immunology at Millennium/Takeda, prior to which he was Director of Clinical Pharmacology and Translation Medicine Research at Centocor/Johnson and Johnson Pharmaceuticals. He supervised and mentored large numbers of high academic-cadre PhD-level scientists and executives. He co-chaired the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Clinical Pharmacology Summit.
Prior to his foray into Industrial Drug Research and Development, Adedigbo Fasanmade spent most of his working life in the academics. He served at a professorial faculty cadre in the Department of Pharmaceutical Biotechnology of the University of Illinois, Chicago. He was also an academic faculty in the Hematology/Oncology section of The University of Chicago and the Director of clinical pharmacology laboratories of The University of Chicago. Prior to that, he served at a lecturer faculty cadre and as Sub-Dean of the Faculty of Pharmacy University of Ibadan, he was also the Chairman of Faculty of Pharmacy Postgraduate Studies at the College of medicine, University of Ibadan. He was a Fogarty International Fellow at the New York State University at Buffalo, USA. Earlier in his career he was a Post Doctoral Fellow of The Royal Society of Chemistry at the University of Bradford, UK. 
Adedigbo Fasanmade has published extensively (Over 100 scientific papers, patents and chapters) in the field of drug development.
In addition to his work on several small-molecule drugs, he participated in the introduction of more than 10 novel monoclonal antibody (biologics) drugs, and antibody-drug-conjugate (ADC) administration to humans. He is instrumental to the full development and Regulatory Approval of several novel drugs such as Remicade (Infliximab), Adcetris (Brentuximab vedotin (ADC)), Stelara (Ustekinumab), Simponi (Golimumab), Entyvio (Vedolizumab) and Reopro (Abciximab) in over 30 countries.  His research experience in drug development cut across multiple therapeutic areas such as immunology, hematology, oncology, cardiovascular, respiratory, gastrointestinal, infectious and inflammation diseases. Adedigbo Fasanmade holds  B.Pharm. and M.Sc. degrees from the University of Ife (OAU); a Ph.D. degree from Dept of Pharmacology, HW University Edinburgh, UK; and a fellow in Pharmacokinetics and Pharmacodynamics from Dept. of Pharmaceutics, State University of New York (SUNY) at Buffalo.
​

Oluwatosin Ariyibi, BSc., MSc.
​Scientific Officer

​Ms. Tosin Ariyibi is a scientist with a strong background in microbiology, virology and immunology. Ms Tosin Ariyibi is the scientific officer at Fastribion. Prior to joining Fastribion, Ms. Ariyibi worked at the Royal Health Post, Ake – Palace, Abeokuta, on various primary healthcare programs including polio and COVID-19 immunization, and family planning. Prior to that, she spent 18 months at the International Institute of Tropical Agriculture (IITA), Ibadan, boosting her research experience in molecular biology and molecular genetics techniques.
Ms. Ariyibi has a BSc. degree from the Osun State University and a MSc. degree from the University of Ibadan.

Adesoji Fasanmade, M.D., MSc., MNBIOL, FWACP.
Chief Medical Officer (CMO)

​Adesoji Fasanmade, is an outstanding medical professional, a professor of medicine and physiology, and an accomplished administrator. Adesoji Fasanmade is the Chief Medical Officer of Fastribion. He is responsible for all strategic planning and monitor of medical teams, pharmacovigilant activities and consultations. He ensures clinical protocol soundness and compliance with all international safety measure bodies. Prior to joining Fastribion, Adesoji Fasanmade has been a professor with the University of Ibadan and University College Hospital (UCH) for several decades, where he served as head of the endocrinology unit.

Adesoji Fasanmade made remarkable advancements in the understanding and treatment of cardiovascular and endocrine disorders. His extensive knowledge and expertise have enriched the academic and medical communities and has positively impacted patient care.

Adesoji Fasanmade has a Bachelor of Medicine, Bachelor of Surgery (MBBS) degree and a Master of Science (MSc) degree in Physiology from the University of Ibadan and a Commonwealth Medical Fellowship at the Institute of Physiology in Glasgow, UK. He is a fellow of the West African College of Physicians.

As a professor of Physiology and Medicine at the University of Ibadan, Adesoji Fasanmade taught a range of subjects, including cardiovascular, respiratory, and metabolic physiology, imparting his expertise to the next generation of healthcare professionals. Adesoji Fasanmade's teaching extends beyond the classroom, as he has supervised numerous research projects, dissertations, and theses at both undergraduate and postgraduate levels.
​
Adesoji Fasanmade's clinical expertise as a consultant physician, has been invaluable in diagnosing and treating patients with complex medical conditions. As the Head of the Endocrine Unit at the Department of Medicine in the University College Hospital, Ibadan, he played a pivotal role in providing high-quality care to patients while actively contributing to medical advancements through his research and publications.
​
In addition to his academic and clinical pursuits, Adesoji Fasanmade has held several administrative positions, including Professor and Dean of the Faculty of Basic Medical Sciences at the University of Medical Sciences, Ondo. He has also served on various accreditation panels, contributing his expertise to enhance medical education and training programs across Nigeria and beyond.
Adesoji Fasanmade's dedication to research is evidenced by his extensive publications and his involvement in reviewing journal articles for reputable scientific publications. He has presented his findings and shared his insights at numerous conferences and symposia worldwide, fostering collaboration and knowledge exchange within the global medical community.
Adesoji Fasanmade has made remarkable contributions to the field of physiology and medicine. His expertise, combined with his commitment to education, clinical practice, and research, has positioned him as a highly respected figure in the medical community, inspiring and mentoring generations of healthcare professionals.

Adam Ademole, BSc.
Technology Officer

Kayode Adebiyi
​Operations Manager

Kemi Ayoola, BSN, RN, PGDE
Global Customer/Contract Manager​